55 results
8-K
EX-10.3
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
will be responsible for all taxes owed on such compensation. No Social Security or Medicare taxes will be paid by CervoMed, and accordingly, Tanner
8-K
EX-10.1
CRVO
CervoMed Inc
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
subsidiaries’ businesses and in their possession or control: (i) a natural person’s name, street address, telephone number, e-mail address, photograph, social
8-K/A
EX-99.2
x436ai
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
424B3
9xfmqlgbii4k4p8zsya
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
m40h4qfeda
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
425
EX-10.1
o7oz53s
19 May 23
Business combination disclosure
4:31pm
8-K
EX-10.1
deblp3
19 May 23
Entry into a Material Definitive Agreement
4:31pm
S-4
e8435 lse
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-2.1
pxt 23j68ddigtkg73
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-2.1
ick7m
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-10.1
joyig3gli 9hp
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
8-K
EX-1.1
koyki
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-10.1
28lqmpf4ens gl5
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am